Market revenue in 2023 | USD 20.7 million |
Market revenue in 2030 | USD 41.1 million |
Growth rate | 10.3% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 59.42% in 2023. Horizon Databook has segmented the Brazil pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
The robust growth & development in biologics and the pharmaceutical market are expected to encourage sterility testing services. The rising competition for drug development and approval is anticipated to improve the demand for pharmaceutical sterility testing services.
According to the data published by the International Trade Administration, Brazil is considered the largest healthcare market in Latin America, allocating 9.47% of its GDP, equivalent to USD 161 billion, toward healthcare expenditures.
In addition, membership of Brazil in the ICH has resulted in the implementation of more regulatory policies regarding the release of drug products. The partnership of laboratories with drug manufacturers is projected to boost the market in Brazil over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account